GlassScriptPhysician profile
Marc L Klein
NPI 1831172246
$4,631.70
in general payments reported to CMS, 2019-2025
16 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $268 · 2021: $156 · 2022: $2,939 · 2023: $260 · 2024: $453 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $942.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,806.57 | 2021-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $699.17 | 2019-2025 | Watchman Access System, Versacross Access Solution |
| Novartis Pharmaceuticals Corporation | $255.88 | 2019-2024 | |
| Abbott Laboratories | $218.93 | 2021-2025 | Aveir, Cardiomems, Mitraclip |
| Edwards Lifesciences Corporation | $169.31 | 2020-2024 | Hemosphere |
| E.R. Squibb & Sons, L.L.C. | $88.01 | 2023-2025 | Camzyos |
| Pfizer INC. | $76.10 | 2019-2025 | |
| Philips North America LLC | $66.61 | 2019 | |
| Cardiva Medical, INC. | $52.32 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.25 | 2019-2023 | Lifevest |
| Lantheus Medical Imaging, INC. | $37.79 | 2023 | Definity |
| Astrazeneca Pharmaceuticals LP | $30.27 | 2022-2024 | Farxiga |
| Merck Sharp & Dohme LLC | $26.98 | 2024 | Verquvo |
| Scpharmaceuticals INC. | $19.96 | 2024 | |
| Teleflex LLC | $17.26 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $16.29 | 2023 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.